Evidence map›Paper›PMID 32850932›Full record

ArticleFrontiers in nutrition2020

Protein for Community-Dwelling Older People: Aspects That Influence the Perception of Commercially Available Protein Drinks.

Lyn Lampmann, Anne Hannink, Eva Kiesswetter, Agnes Emberger-Klein, Dorothee Volkert, Klaus Menrad

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lyn LampmannChair of Marketing and Management of Biogenic Resources, Weihenstephan-Triesdorf University of Applied Sciences, Technical University of Munich Straubing for Biotechnology and Sustainability, Straubing, Germany.
Anne HanninkInstitute for Biomedicine of Aging, Friedrich-Alexander University of Erlangen-Nuremberg, Nuremberg, Germany.
Eva KiesswetterInstitute for Biomedicine of Aging, Friedrich-Alexander University of Erlangen-Nuremberg, Nuremberg, Germany.
Agnes Emberger-KleinChair of Marketing and Management of Biogenic Resources, Weihenstephan-Triesdorf University of Applied Sciences, Technical University of Munich Straubing for Biotechnology and Sustainability, Straubing, Germany.
Dorothee VolkertInstitute for Biomedicine of Aging, Friedrich-Alexander University of Erlangen-Nuremberg, Nuremberg, Germany.
Klaus MenradChair of Marketing and Management of Biogenic Resources, Weihenstephan-Triesdorf University of Applied Sciences, Technical University of Munich Straubing for Biotechnology and Sustainability, Straubing, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEWeihenstephan-Triesdorf University of Applied Sciences · DETechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In an aging population, support for independent living is increasingly critical for older generations. Currently, sarcopenia is a major cause of frailty, which increases the risk of decreased mobility, falls, morbidity, and mortality and leads to dependence on third parties. Sarcopenia is preventable by consumption of adequate protein. However, many older people do not meet the recommended daily allowance of protein, thereby supporting dependence rather than independent living. Current literature indicates that a protein drink could be an appropriate product for older peoples' protein consumption. We were interested in autonomous persons whose nutritional decisions were still self-determined and thus could preventively influence their personal health. This study evaluated three commercially available protein drinks in three focus groups (

Indexed as

enable clusterfocus groupsolder peopleperceptionprotein

Identifiers

PMID32850932
PMCPMC7401965
OpenAlexW3045821004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.